|
1
|
Inch WR, McCredie JA and Sutherland RM:
Growth of nodular carcinomas in rodents compared with multi-cell
spheroids in tissue culture. Growth. 34:271–282. 1970.PubMed/NCBI
|
|
2
|
Sutherland RM, McCredie JA and Inch WR:
Growth of multicell spheroids in tissue culture as a model of
nodular carcinomas. J Natl Cancer Inst. 46:113–120. 1971.PubMed/NCBI
|
|
3
|
Breslin S and O'Driscoll L:
Three-dimensional cell culture: The missing link in drug discovery.
Drug Discov Today. 18:240–249. 2013. View Article : Google Scholar
|
|
4
|
Kimlin LC, Casagrande G and Virador VM: In
vitro three-dimensional (3D) models in cancer research: An update.
Mol Carcinog. 52:167–182. 2013. View
Article : Google Scholar
|
|
5
|
Mueller-Klieser W: Tumor biology and
experimental therapeutics. Crit Rev Oncol Hematol. 36:123–139.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rainaldi G, Calcabrini A, Arancia G and
Santini MT: Differential expression of adhesion molecules (CD44,
ICAM-1 and LFA-3) in cancer cells grown in monolayer or as
multicellular spheroids. Anticancer Res. 19:1769–1778.
1999.PubMed/NCBI
|
|
7
|
Erler JT and Weaver VM: Three-dimensional
context regulation of metastasis. Clin Exp Metastasis. 26:35–49.
2009. View Article : Google Scholar :
|
|
8
|
Frixen UH, Behrens J, Sachs M, Eberle G,
Voss B, Warda A, Löchner D and Birchmeier W: E-cadherin-mediated
cell-cell adhesion prevents invasiveness of human carcinoma cells.
J Cell Biol. 113:173–185. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen A, Beetham H, Black MA, Priya R,
Telford BJ, Guest J, Wiggins GA, Godwin TD, Yap AS and Guilford PJ:
E-cadherin loss alters cytoskeletal organization and adhesion in
non-malignant breast cells but is insufficient to induce an
epithelial-mesenchymal transition. BMC Cancer. 14:5522014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hollestelle A, Peeters JK, Smid M,
Timmermans M, Verhoog LC, Westenend PJ, Heine AA, Chan A, Sieuwerts
AM, Wiemer EA, et al: Loss of E-cadherin is not a necessity for
epithelial to mesenchymal transition in human breast cancer. Breast
Cancer Res Treat. 138:47–57. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jeanes A, Gottardi CJ and Yap AS:
Cadherins and cancer: How does cadherin dysfunction promote tumor
progression? Oncogene. 27:6920–6929. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Onder TT, Gupta PB, Mani SA, Yang J,
Lander ES and Weinberg RA: Loss of E-cadherin promotes metastasis
via multiple downstream transcriptional pathways. Cancer Res.
68:3645–3654. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Canel M, Serrels A, Frame MC and Brunton
VG: E-cadherin-integrin crosstalk in cancer invasion and
metastasis. J Cell Sci. 126:393–401. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Borghi N, Lowndes M, Maruthamuthu V,
Gardel ML and Nelson WJ: Regulation of cell motile behavior by
crosstalk between cadherin- and integrin-mediated adhesions. Proc
Natl Acad Sci USA. 107:13324–13329. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kaufhold S and Bonavida B: Central role of
Snail1 in the regulation of EMT and resistance in cancer: A target
for therapeutic intervention. J Exp Clin Cancer Res. 33:622014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhao D, Tang XF, Yang K, Liu JY and Ma XR:
Over-expression of integrin-linked kinase correlates with aberrant
expression of Snail, E-cadherin and N-cadherin in oral squamous
cell carcinoma: Implications in tumor progression and metastasis.
Clin Exp Metastasis. 29:957–969. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Takei N, Yoneda A, Sakai-Sawada K, Kosaka
M, Minomi K and Tamura Y: Hypoxia-inducible ERO1α promotes cancer
progression through modulation of integrin-β1 modification and
signalling in HCT116 colorectal cancer cells. Sci Rep. 7:93892017.
View Article : Google Scholar
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
19
|
De Crevoisier R, Baudin E, Bachelot A,
Leboulleux S, Travagli JP, Caillou B and Schlumberger M: Combined
treatment of anaplastic thyroid carcinoma with surgery,
chemotherapy, and hyperfractionated accelerated external
radiotherapy. Int J Radiat Oncol Biol Phys. 60:1137–1143. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kebebew E, Greenspan FS, Clark OH, Woeber
KA and McMillan A: Anaplastic thyroid carcinoma. Treatment outcome
and prognostic factors Cancer. 103:1330–1335. 2005.
|
|
21
|
Kondo T, Ezzat S and Asa SL: Pathogenetic
mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer.
6:292–306. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ivanova K, Ananiev J, Aleksandrova E,
Ignatova MM and Gulubova M: Expression of E-cadherin/beta-catenin
in epithelial carcinomas of the thyroid gland. Open Access Maced J
Med Sci. 5:155–159. 2017.PubMed/NCBI
|
|
23
|
Brabant G, Hoang-Vu C, Cetin Y, Dralle H,
Scheumann G, Mölne J, Hansson G, Jansson S, Ericson LE and Nilsson
M: E-cadherin: A differentiation marker in thyroid malignancies.
Cancer Res. 53:4987–4993. 1993.PubMed/NCBI
|
|
24
|
Oliveira-Ferrer L, Legler K and
Milde-Langosch K: Role of protein glycosylation in cancer
metastasis. Semin Cancer Biol. 44:141–152. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Guo HB, Lee I, Kamar M, Akiyama SK and
Pierce M: Aberrant N-glycosylation of beta1 integrin causes reduced
alpha5beta1 integrin clustering and stimulates cell migration.
Cancer Res. 62:6837–6845. 2002.PubMed/NCBI
|
|
26
|
Gahmberg CG, Gronholm M and Uotila LM:
Regulation of integrin activity by phosphorylation. Adv Exp Med
Biol. 819:85–96. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Coleman DT, Soung YH, Surh YJ, Cardelli JA
and Chung J: Curcumin prevents palmitoylation of integrin β4 in
breast cancer cells. PLoS One. 10:e01253992015. View Article : Google Scholar
|
|
28
|
Isaji T, Sato Y, Fukuda T and Gu J:
N-glycosylation of the I-like domain of beta1 integrin is essential
for beta1 integrin expression and biological function:
Identification of the minimal N-glycosylation requirement for
alpha5beta1. J Biol Chem. 284:12207–12216. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Marsico G, Russo L, Quondamatteo F and
Pandit A: Glycosylation and integrin regulation in cancer. Trends
Cancer. 4:537–552. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Miyoshi E, Ito Y and Miyoshi Y:
Involvement of aberrant glycosylation in thyroid cancer. J Oncol.
2010:8165952010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wong SHM, Fang CM, Chuah LH, Leong CO and
Ngai SC: E-cadherin: Its dysregulation in carcinogenesis and
clinical implications. Crit Rev Oncol Hematol. 121:11–22. 2018.
View Article : Google Scholar
|
|
32
|
Ganguly KK, Pal S, Moulik S and Chatterjee
A: Integrins and metastasis. Cell Adh Migr. 7:251–261. 2013.
View Article : Google Scholar : PubMed/NCBI
|
